# K200502: Myriad Particles

- Pathway: 510(k) (Traditional)
- Applicant: Aroa Biosurgery, Ltd.
- Decided: Mar 31, 2021 after 397 days
- Product code: KGN (Wound Dressing With Animal-Derived Material(S))
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K921895 (1992). 37 ancestors in all.
4 later devices descend from it; 1 cites it directly.
0 of 42 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K092096: Endoform Dermal Template, Mesynthes, Ltd. (2010) Summary page 4.

## Most influential descendants
- K231325: Corplex P / Theracor P / Allacor P (2024), 3 descendants of its own
- K253204: Catalyze (2026), 0 descendants of its own
- K253339: Theracor (2025), 0 descendants of its own
- K242828: Corplex P/ Theracor P/ Allacor P (2024), 0 descendants of its own

## Indications for use
Myriad™ Particles is indicated for use in the management of the following wounds: partial and full-thickness wounds pressure ulcers venous ulcers diabetic ulcers chronic vascular ulcers tunneled/undermined wounds Surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence) trauma wounds (abrasions, lacerations, partial-thickness burns, and skin tears) draining wounds

Source page: https://510kreport.com/device/K200502
Methodology: https://510kreport.com/methodology